|Audit||Nominating and Governance||Compensation||Strategic|
|John T. Henderson, M.D.|
|Lawrence C. Best|
|Heiner Dreismann, Ph.D.|
|Walter Gilbert, Ph.D.|
Director, Vice Chairman of the Board
Managing Director, BioVentures Investors
Walter Gilbert, Ph.D., Vice Chairman of the Board of Directors, joined the Company as a founding scientist in March 1992. Dr. Gilbert won the Nobel Prize in Chemistry in 1980 for his contributions to the development of DNA sequencing technology. He was a founder of Biogen, Inc. and its Chairman of the Board and Chief Executive Officer from 1981 to 1985, as well as the Carl M. Loeb University Professor at Harvard University. He is presently a Managing Director of BioVentures Investors.
|Dennis Langer, M.D, J.D.|
|S. Louise Phanstiel|
Stock transaction information provided by EDGAR Online. Myriad Genetics, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.
Stock Quote (NASDAQ:MYGN)
Provided by eSignal.
Corporate Communications and Media Relations